China Pharmaceutical Industry Cooperation and Development Forum

On November 4-5, Shandong Pharmaceutical Industry Association, will be in Ji'nan China medical Chemease jointly organized the 2016 Chinese pharmaceutical industry cooperation and development forum, invite you to participate in. In 2016 the first half of the pharmaceutical industry heavy industry policy frequent, rectification from the pharmaceutical field gradually extended to the medical, pharmaceutical and medicine etc.. In a number of policy heavy attack, the short-term development of the pharmaceutical industry may be limited, but in the long term, the policy of strict regulation will gradually eliminate inferior products in the market, the industry ushered in the "reshuffle" stage, segments of the leading enterprises will benefit to promote the rectification of their respective industries. Consistency in the evaluation, the camp changed by two ticket system and other pharmaceutical industry rectification policy to promote, leading companies will also use their own advantages to actively carry out industry mergers and acquisitions, industry concentration is expected to enhance.
Under this background, the 2016 China pharmaceutical industry cooperation and development forum will focus on industrial policy, to explore opportunities for cooperation, promote the process of internationalization of Chinese pharmaceutical industry, providing the latest industry information industry peers, the opportunity to cross-border exchanges, and jointly promote the rapid development of China pharmaceutical industry.

Part of the hot topics of the meeting:
Interpretation and opportunity of the related policy on the evaluation of the consistency of generic drugs
Two tickets system and replacing business tax with value-added tax(VAT) full implementation of the strategy, pharmaceutical companies
Chinese pharmaceutical enterprises to internationalization, the use of global resources development
International Development Prospect of marine biological medicine
Advances in research and development of biological macromolecular drugs
The research status and development trend of small molecule targeted drugs
Develop and promote the innovation of pharmaceutical industry
Generic evaluation of generic drug selection strategies
Interpretation of the key points of consistency evaluation from the perspective of CRO
......
Part of the proposed invitation of enterprises:
Pharmaceutical cttq, Hengrui medicine, Huahai, Haosen pharmaceutical, Fosun Pharmaceutical, Shijiazhuang Pharmaceutical Group, humanwell pharmaceutical, pharmaceutical, pharmaceutical, pharmaceutical, Qilu green AstraZeneca, Pfizer, Bayer, Wuxi and so on......